Copyright
©The Author(s) 2021.
World J Diabetes. Dec 15, 2021; 12(12): 2107-2118
Published online Dec 15, 2021. doi: 10.4239/wjd.v12.i12.2107
Published online Dec 15, 2021. doi: 10.4239/wjd.v12.i12.2107
Table 2 The comparison of the clinical and sociodemographic characteristics of patients with type 2 diabetes mellitus with and without seasonal influenza and pneumococcal vaccination status
Patients with T2DM, n = 4721 | ||||||
Influenza vac (+), n = 1003 (21.2%) | Influenza vac (-), n = 3718 (78.8%) | P value | Pneumo. vac (+), n = 330 (7.0%) | Pneumo. vac (-), n = 4366 (93.0%) | P value | |
Sex (female) | 525 (52.3) | 2251 (60.5) | < 0.001 | 180 (54.5) | 2581 (59.1) | < 0.001 |
Age (yr) | 62.22 ± 9.93 | 57.44 ± 10.36 | < 0.001 | 63.97 ± 9.83 | 58.02 ± 10.38 | < 0.001 |
Diabetes duration (yr) | 13.62 ± 8.36 | 10.08 ± 7.09 | < 0.001 | 14.10 ± 8.84 | 10.57 ± 7.36 | < 0.001 |
BMI (kg/m2) | 31.60 ± 6.28 | 32.39 ± 6.65 | 0.004 | 31.08 ± 5.94 | 32.21 ± 6.61 | < 0.001 |
SBP office (mm Hg) | 133.32 ± 18.15 | 132.34 ± 18.40 | 0.138 | 133.83 ± 17.63 | 132.46 ± 18.40 | 0.191 |
DBP office (mm Hg) | 79.56 ± 10.84 | 80.81 ± 10.79 | 0.001 | 78.90 ± 10.28 | 80.67 ± 10.86 | 0.004 |
HbA1c (%) (mmol/mol) | 7.54 ± 1.59 (58.95 ± 17.41) | 7.79 ± 1.78 (61.62 ± 19.49) | < 0.001 | 7.44 ± 1.59 (57.80 ± 17.33) | 7.76 ± 1.76 (61.29 ± 19.20) | 0.001 |
LDL-C (mg/dL) | 109.27 ± 35.76 | 115.13 ± 36.15 | < 0.001 | 107.80 ± 35.82 | 114.32 ± 36.14 | 0.002 |
TG (mg/dL) | 169.75 ± 100.06 | 185.77 ± 136.46 | 0.001 | 172.21 ± 111.17 | 183.20 ± 131.21 | 0.144 |
HDL-C (mg/dL) | 46.81 ± 12.55 | 46.46 ± 13.04 | 0.464 | 47.63 ± 11.91 | 46.43 ± 12.97 | 0.109 |
Macrovascular complications, n (%) | 317 (31.6) | 827 (22.2) | < 0.001 | 119 (36.1) | 1013 (23.2) | < 0.001 |
Microvascular complications, n (%) | 509 (50.7) | 1734 (46.6) | 0.021 | 175 (53.0) | 2058 (47.1) | 0.039 |
Higher education, n (%) | 461 (46.7) | 1331 (36.3) | < 0.001 | 155 (47.7) | 1630 (37.9) | < 0.001 |
Private care center, n (%) | 154 (15.4) | 319 (8.6) | < 0.001 | 154 (15.4) | 319 (8.6) | < 0.001 |
Lower income, n (%) | 237 (29.8) | 981 (33.5) | 0.052 | 54 (23.9) | 1157 (33.2) | 0.004 |
Current smoking, n (%) | 108 (10.8) | 491 (13.3) | 0.039 | 26 (7.9) | 570 (13.1) | 0.006 |
Regular exercise, n (%) | 226 (22.9) | 688 (18.8) | 0.003 | 87 (26.7) | 824 (19.2) | 0.001 |
Obesity, n (%) | 548 (55.2) | 2180 (59.4) | 0.016 | 173 (52.9) | 2538 (58.9) | 0.034 |
Hypertension, n (%) | 768 (77.0) | 2433 (65.9) | < 0.001 | 258 (78.7) | 2924 (67.4) | < 0.001 |
Dyslipidemia, n (%) | 939 (95.0) | 3457 (95.1) | 0.989 | 310 (94.8) | 4061 (95.1) | 0.835 |
Statin treatment, n (%) | 531 (52.9) | 1333 (35.9) | < 0.001 | 196 (59.4) | 1659 (38.0) | < 0.001 |
Achieving targets, n (%) | ||||||
HbA1c on target (< 7%) (53 mmol/mol) | 434 (44.2) | 1417 (39.1) | 0.004 | 165 (50.8) | 1677 (39.4) | < 0.001 |
BP on target (< 130/80 mg/dL) | 700 (70.4) | 2563 (69.6) | 0.636 | 249 (75.9) | 2999 (69.4) | 0.013 |
LDL-C on target (< 100 mg/dL) | 422 (43.6) | 1245 (35.5) | < 0.001 | 141 (43.9) | 1517 (36.7) | 0.010 |
- Citation: Demirci I, Haymana C, Salman S, Tasci I, Corapcioglu D, Kirik A, Yetkin İ, Altay M, Sabuncu T, Bayram F, Satman I, Sonmez A, TEMD Study Group. Rates and associates of influenza and pneumococcus vaccination in diabetes mellitus: A nationwide cross-sectional study (TEMD vaccination study). World J Diabetes 2021; 12(12): 2107-2118
- URL: https://www.wjgnet.com/1948-9358/full/v12/i12/2107.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i12.2107